{
    "meta": {
        "totalResults": 385,
        "from": 20
    },
    "results": [
        {
            "aliases": [
                {
                    "type": "Synonym",
                    "name": "153Sm-DOTMP"
                },
                {
                    "type": "ChemicalStructureName",
                    "name": "Sm-153-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayltetrakis(methylene)tetrakisphosphonic acid"
                },
                {
                    "type": "USBrandName",
                    "name": "CycloSam"
                },
                {
                    "type": "Synonym",
                    "name": "Sm-153-DOTMP"
                },
                {
                    "type": "Synonym",
                    "name": "153 Sm-DOTMP"
                },
                {
                    "type": "ChemicalStructureName",
                    "name": "Sm-153-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetra(methylene)phosphonic acid"
                }
            ],
            "definition": {
                "html": "A radioconjugate composed of the phosphonic acid chelator DOTMP (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetramethylenephosphonic acid) conjugated to the beta- and gamma-emitting radioisotope samarium Sm 153, with potential antineoplastic activity. Upon administration of samarium Sm 153-DOTMP, the DOTMP moiety targets and binds to growing bone, thereby selectively delivering samarium Sm 153-mediated cytotoxic radiation to bone tumor and metastases, which may help destroy bone metastases and mitigate pain from bone metastases. Check for <a ref=\"https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C165558\">active clinical trials</a> using this agent. (<a ref=\"https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C165558\">NCI Thesaurus</a>)",
                "text": "A radioconjugate composed of the phosphonic acid chelator DOTMP (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetramethylenephosphonic acid) conjugated to the beta- and gamma-emitting radioisotope samarium Sm 153, with potential antineoplastic activity. Upon administration of samarium Sm 153-DOTMP, the DOTMP moiety targets and binds to growing bone, thereby selectively delivering samarium Sm 153-mediated cytotoxic radiation to bone tumor and metastases, which may help destroy bone metastases and mitigate pain from bone metastases. Check for active clinical trials using this agent. (NCI Thesaurus)"
            },
            "drugInfoSummaryLink": null,
            "nciConceptId": "C165558",
            "nciConceptName": "Samarium Sm 153-DOTMP",
            "termId": 799673,
            "name": "samarium Sm 153-DOTMP",
            "firstLetter": "s",
            "type": "DrugTerm",
            "termNameType": "PreferredName",
            "prettyUrlName": "samarium-sm-153-dotmp"
        },
        {
            "preferredName": "diphencyprone",
            "termId": 742143,
            "name": "Samcyprone",
            "firstLetter": "s",
            "type": "DrugAlias",
            "termNameType": "USBrandName",
            "prettyUrlName": "diphencyprone"
        },
        {
            "preferredName": "granisetron transdermal system",
            "termId": 642824,
            "name": "Sancuso",
            "firstLetter": "s",
            "type": "DrugAlias",
            "termNameType": "USBrandName",
            "prettyUrlName": "granisetron-transdermal-patch"
        },
        {
            "preferredName": "granisetron",
            "termId": 794007,
            "name": "Sancuso",
            "firstLetter": "s",
            "type": "DrugAlias",
            "termNameType": "USBrandName",
            "prettyUrlName": "granisetron"
        },
        {
            "preferredName": "cyclosporine",
            "termId": 39201,
            "name": "Sandimmun",
            "firstLetter": "s",
            "type": "DrugAlias",
            "termNameType": "USBrandName",
            "prettyUrlName": "cyclosporine"
        },
        {
            "preferredName": "cyclosporine",
            "termId": 39201,
            "name": "Sandimmune",
            "firstLetter": "s",
            "type": "DrugAlias",
            "termNameType": "USBrandName",
            "prettyUrlName": "cyclosporine"
        }
    ],
    "links": null
}